Other languages Clarus Corporation

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
6.28 ^USD	+3.46%		+0.64%	-8.92%

03-13	Roth MKM Adjusts Price Target on Clarus to $7.50 From $6.50, Maintains Buy Rating	MT
03-11	Transcript : Clarus Corporation - Analyst/Investor Day

Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	03-08
Sector Update: Consumer Stocks Decline in Afternoon Trading	03-08
Clarus Board Approves Requests to Increase Ownership From Two Shareholders; Shares Jump	03-08
Clarus Corporation Appoints Roger Werner to Its Board of Directors	03-08
Clarus Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-07
Clarus Corporation Provides Earnings Guidance for the Fiscal Year 2024	03-07
Clarus Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-07
Clarus Corporation Announces Regular Quarterly Cash Dividend, Payable on March 28, 2024	03-05
Silynxcom Gets Additional $400,000 Order for Clarus Headset System; Shares Rise	01-23
Clarus Corporation Announces the Resignation of James E. Walker III as a Director	01-09
Sector Update: Consumer Stocks Mixed in Afternoon Trading	01-02
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading	01-02
Sector Update: Consumer Stocks Slip Pre-Bell Tuesday	01-02
Sector Update: Consumer	01-02
Clarus to Sell Precision Sport Segment for $175 Million	12-29
Blackstone explores sale of Anthos Therapeutics -sources	12-04
Blackstone explora la venta de Anthos Therapeutics: fuentes	12-04
Blackstone explores sale of Anthos Therapeutics -sources	12-04
Clarus Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07
Clarus Corporation Provides Earnings Guidance for the Year 2023	11-07

No results for this search